Application of immobilized enzymes to clinical analyses : use of co-immobilized glucose oxidase and peroxidase in column form.

Summary

# Editorial Summary Researchers developed a laboratory analytical system by bonding glucose oxidase and peroxidase enzymes directly onto glass beads and packing them into a compact column, which could then be integrated into automated clinical chemistry analysers to measure blood glucose rapidly. Testing this co-immobilized enzyme approach on serum samples demonstrated superior sensitivity compared to columns containing separately immobilised enzymes, whilst maintaining reliable performance for at least two months of continuous use and producing results that matched established glucose measurement methods. The ability to process 60 samples hourly whilst handling glucose concentrations up to 5.0 g/l suggests potential applications for high-throughput screening in equine practice, particularly useful for monitoring metabolic conditions such as equine metabolic syndrome or hyperinsulinaemia where rapid, accurate glucose quantification aids clinical decision-making. Enzyme immobilisation technology of this type addresses a longstanding challenge in laboratory automation—reducing reagent costs and improving assay consistency—though practitioners should note this paper precedes modern point-of-care testing devices now commonly used in equine veterinary practice.

Read the full abstract on PubMed

Key Findings

• •Co-immobilized glucose oxidase and peroxidase on alkylamine glass beads achieved glucose determination rates of 60 samples per hour up to 5.0 g/l in serum
• •Co-immobilized enzyme column demonstrated better sensitivity compared to columns with individually immobilized enzymes
• •Enzyme column remained stable for two months of continuous use
• •Results correlated satisfactorily with established glucose assay methods